Gofen & Glossberg LLC Northwest Biotherapeutics Inc Call Options Transaction History
Gofen & Glossberg LLC
- $3.89 Billion
- Q4 2022
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding NWBO
# of Institutions
13Shares Held
746KCall Options Held
0Put Options Held
0-
Moloney Securities Asset Management, LLC489KShares$122,1300.02% of portfolio
-
Vsm Wealth Advisory, LLC Hunt Valley, MD65.6KShares$16,3930.01% of portfolio
-
Opus Capital Group, LLC60.2KShares$15,0370.0% of portfolio
-
Williams Jones Wealth Management, Llc. New York, NY35KShares$8,7500.0% of portfolio
-
Ethos Financial Group, LLC King Of Prussia, PA23.7KShares$5,9250.0% of portfolio
About NORTHWEST BIOTHERAPEUTICS INC
- Ticker NWBO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 1,037,230,016
- Market Cap $259M
- Description
- Northwest Biotherapeutics, Inc., a biotechnology company, develops personalized immune therapies for cancer in the United States and internationally. The company develops its products based on DCVax, a platform technology that uses activated dendritic cells to mobilize a patient's own immune system to attack cancer. Its lead product, DCVax-L, wh...